Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
出版年份 2014 全文链接
标题
Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
作者
关键词
-
出版物
PROTEIN ENGINEERING DESIGN & SELECTION
Volume 27, Issue 6, Pages 179-190
出版商
Oxford University Press (OUP)
发表日期
2014-04-26
DOI
10.1093/protein/gzu010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MT-LOOP-dependent Localization of Membrane Type I Matrix Metalloproteinase (MT1-MMP) to the Cell Adhesion Complexes Promotes Cancer Cell Invasion
- (2013) Anna M. Woskowicz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1–MMP
- (2013) S A Shiryaev et al. Oncogenesis
- ADAM-17: a novel therapeutic target for triple negative breast cancer
- (2012) P. M. McGowan et al. ANNALS OF ONCOLOGY
- Rezymogenation of active urokinase induced by an inhibitory antibody
- (2012) Longguang Jiang et al. BIOCHEMICAL JOURNAL
- EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
- (2012) Christine M. Ardito et al. CANCER CELL
- Improvements to the Kunkel mutagenesis protocol for constructing primary and secondary phage-display libraries
- (2012) Renhua Huang et al. METHODS
- Primer Extension Mutagenesis Powered by Selective Rolling Circle Amplification
- (2012) Tuomas Huovinen et al. PLoS One
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- Cross-domain inhibition of TACE ectodomain
- (2011) C. J. Tape et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue inhibitors of metalloproteinases
- (2011) Gillian Murphy GENOME BIOLOGY
- Thiol isomerases negatively regulate the cellular shedding activity of ADAM17
- (2010) Sofie H. Willems et al. BIOCHEMICAL JOURNAL
- Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17
- (2010) S. Van Schaeybroeck et al. CANCER RESEARCH
- Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer
- (2010) Fusanori Yotsumoto et al. CANCER SCIENCE
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site
- (2010) S. M. Le Gall et al. JOURNAL OF CELL SCIENCE
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- ADAM17 as a Therapeutic Target in Multiple Diseases
- (2009) Joaquin Arribas et al. CURRENT PHARMACEUTICAL DESIGN
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge
- (2008) Dimitris Georgiadis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Current perspective of TACE inhibitors: A review
- (2008) Shirshendu DasGupta et al. BIOORGANIC & MEDICINAL CHEMISTRY
- TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer
- (2008) N. B. Merchant et al. CLINICAL CANCER RESEARCH
- The ADAM metalloproteinases
- (2008) D EDWARDS et al. MOLECULAR ASPECTS OF MEDICINE
- Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response
- (2008) Howard R. Mellor et al. PHARMACOLOGY
- Regulation of the proteolytic disintegrin metalloproteinases, the ‘Sheddases’
- (2008) Gillian Murphy SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
- (2008) Marcia L Moss et al. Nature clinical practice. Rheumatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started